Isopropyl isocyanate → 4-(3-Bromoimidazo[1,2-b]pyridazin-6-yl)-N-isopropylpiperazine-1-carboxamide
Reaction equation
[N:1]([CH:4]([CH3:6])[CH3:5])=[C:2]=[O:3].[Br:7][C:8]1[N:12]2[N:13]=[C:14]([N:17]3[CH2:22][CH2:21][NH:20][CH2:19][CH2:18]3)[CH:15]=[CH:16][C:11]2=[N:10][CH:9]=1>ClCCl>[Br:7][C:8]1[N:12]2[N:13]=[C:14]([N:17]3[CH2:18][CH2:19][N:20]([C:2]([NH:1][CH:4]([CH3:6])[CH3:5])=[O:3])[CH2:21][CH2:22]3)[CH:15]=[CH:16][C:11]2=[N:10][CH:9]=1Participants
4
Procedure
2-Isocyanatopropane [1795-48-8] (120 μL, 1.2 mmol) was added, via syringe, to a stirred, ambient temperature, clear, colorless solution of 3-bromo-6-piperazin-1-yl-imidazo[1,2-b]pyridazine (334.6 mg, 1.2 mmol) in dichloromethane (20 mL). The solution was allowed to proceed for 17 h then evaporated to dryness to afford 481.5 mg of light yellow solid foam. LRMS (ESI) m/z 367.0/369.0 [(M+H)]+, calc'd for C14H19BrN6O: 367.25.
Workup
- customthen evaporated to dryness
Sources & evidence
- ORD record
- ord-e94f7ba7d33f458093e680847647737b
- Source dataset
- uspto-grants-2015_03
- Patent number
- US08969565B2
Reaction notes
Loading…